ROS-Mediated Selective Killing Effect of Black Phosphorus: Mechanistic Understanding and Its Guidance for Safe

Na Kong1, Xiaoyuan Ji1, Junqing Wang1

  • 1Center for Nanomedicine and Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, United States.

Nano Letters
|April 4, 2020
PubMed

Insights

Black phosphorus (BP) nanosheets selectively kill cancer cells by inducing reactive oxygen species (ROS). However, exceeding a specific dose range can harm normal tissues, highlighting the need for careful application in biomedical therapies.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Black phosphorus (BP)-based nanomaterials show promise in biomedicine.
  • Their biological effects and mechanisms, especially in cancer therapy, are not fully understood.

Purpose of the Study:

  • To elucidate the mechanism behind the selective killing of cancer cells by BP-based nanosheets.
  • To investigate the role of reactive oxygen species (ROS) in this process.
  • To determine the safety profile and dosage limitations of BP-based nanomaterials in vivo.

Main Methods:

  • Systematic investigation of BP-based nanosheets' effects on cancer and normal cells.
  • Measurement of ROS levels, superoxide dismutase activity, and lipid peroxidation.
  • Analysis of cellular responses including cytoskeleton changes, cell cycle arrest, DNA damage, and apoptosis.
  • Evaluation of pathological changes in normal organs at different dosages.

Main Results:

  • BP-based nanosheets induce higher ROS levels in cancer cells than normal cells, leading to cancer cell death.
  • Decreased superoxide dismutase activity due to lipid peroxides is a key mechanism for selective ROS generation in cancer cells.
  • A specific dosage range (SK range) is critical for selective cancer cell killing; exceeding this range causes ROS production and damage in normal tissues.

Conclusions:

  • BP-based nanosheets offer a novel ROS-mediated mechanism for selective cancer cell killing.
  • Understanding the "SK range" is crucial for safe and effective application of BP-based therapies.
  • These findings provide critical insights for the development of safe BP-based biomedical applications.